Accelr8 Technology Corp.

Accelr8 Technology Corporation is a developer of innovative materials and instrumentation for advanced applications in medical diagnostics, basic research, drug discovery, and bio-detection. Accelr8 is developing a new diagnostic platform, the BACcelr8r™, based on its proprietary surface coatings, assay processing, and detection technologies. The company intends the BACcelr8r™ to become the world’s first diagnostic system to provide bacterial identification and quantitation in 2 hours or less, and complete antibiotic resistance strain identification in 8 hours or less. Standard culturing typically delays lab results from one to three days, which is far beyond the short time window that physicians have available to assure adequate initial therapy for a life-threatening hospital acquired infection (HAI).

Technology components include –

• Integrated analytical systems
• OptiChem® bio-coatings
• Assay acceleration, analyte concentration, and sample preparation for rare analytes
  • Microbial and cellular analytes
  • Molecular analytes
• Assay detection and image analysis
• Instrumentation and fluidics